Chemicals

Zinc trifluoromethanesulfonate Cas:54010-75-2

We are Zinc trifluoromethanesulfonate CAS:54010-75-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Synonyms：

Trifluoromethanesulfonic acid zinc salt

zinc,trifluoromethanesulfonate

Zinc(II) Trifluoromethanesulfonate

Zinc(II) Triflate

Trifluoromethanesulfonic Acid Zinc(II) Salt

Zinc triflate

Molecular Formula: C2F6O6S2Zn

Molecular weight：363.51800

Appearance and properties: white to light gray powder

Density: 4.43

Boiling point: 162ºC at 760 mmHg

Melting point: ≥300 °C(lit.)

Storage conditions: Refrigerator

Our company is committed to establishing a complete fluorochemical products and technology platform to provide customers with convenient one-stop services. Our products are widely used in the manufacture of new materials, pharmaceutical research and development and the development of new pesticides. The fluorine product categories include fluorine-containing material raw materials, fluorinated reagents, fluorine-containing building blocks, fluorine-containing reagents and fluorine-containing gases for synthesis. Shanghai Fluorine Technology will strive to build a complete industrial chain from fluorine-containing raw material procurement, fluorination technology research and development, fluorine-containing product production, fluorine-containing product storage, fluorine-containing product quality control and fluorine-containing product application.

Market News: A possible reason for this is that developments within the biocatalysis field have fast outpaced existing knowhow, leaving some pharmaceutical companies unaware of the vast range of options available. Keeping abreast of both current and emerging developments within the field of biocatalytic processing is key when it comes to maintaining a competitive edge.10-((4-((Z)-(3,6-dioxo-5-((Z)-4-(thiophene-2-carboxamido)benzylidene)piperazin-2-ylidene)methyl)phenyl)amino)-10-oxodecanoic acid manufacturer.CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 4-(4-amino-phenyl)-[1,4]-diazepan-1-carboxamidine supplier In 2021, the combo has raked in $818 million in the first half of the year alone for Novartis, a number that is already up 11% from last year. Comparatively, Roche reported $218 million in sales of Zelboraf in 2016, and revenue was not reported in its most recent mid-year update. 2α-(1-Hydroxy-1-methyl)-ethyl-cholestanon-(3) producer

Product Name
Selumetinib Cas:606143-52-6	View Details
2-Bromovaleric acid	View Details
Ethoxyquin 95% Cas:91-53-2	View Details